AHCO Company Profile and Key Details

AdaptHealth Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $23.01. This means the shares are trading below this model’s fair value.

AdaptHealth Corp. has 133.41 million shares outstanding. The public float is 85.77 million shares, elevated short interest at 10.37% of float. This equals 10.39 million shares. The short ratio is 2.34 days. Institutional investors hold 116.14% of the float. Insiders own 8.14%. OEP VII GP, L.L.C. holds 16.31 million shares, CASHIN RICHARD M JR has 16.31 million shares and Everest Hill Group Inc. has 12.81 million shares. Over the past six months, insider transactions show net buying. They sold 22.55 thousand shares across 2 transactions.

Short-term trend indicators are mixed aligned (SMA20 -10.03%, SMA50 -10.96%, SMA200 -4.14%). The stock’s 14-day RSI is 36.77 (weak momentum), while the ATR of 0.5 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.93% below its high and over 27.8% above its low. Average 10-day trading volume of 3.20 million shares is slightly above the 3-month average of 2.79 million, indicating heightened recent market interest.

AdaptHealth Corp. generated EPS of -$0.53 over the past year. Five-year average earnings growth is 29.83%. Wall Street analysts project EPS growth of 29.34% annually over the next five years. The latest quarter delivered EPS of $0.06. The next quarter is forecast at $0.01. Next year's EPS is expected at -$3.59. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 6 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $16.00 to $9.00. The high target offers 180.21% upside. The low target suggests 57.62% downside. The mean target is $13.78. This offers 141.33% upside. AdaptHealth Corp. earnings surprise history is frequent misses against expectations. The quarter that ended August 04, 2026, missed forecasts by -64.45%. The prior quarter beat by -580.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 06, 2025.

AdaptHealth Corp. (NASDAQ:AHCO) closed at $5.71 USD, losing -$0.05 (-0.87%) from the previous close of $5.76. The stock is currently mid-range between its 52-week high and low $5.21 and $13.43. With a market capitalization of about $776.87 million, AdaptHealth Corp. is classified as a small-cap and shows higher-than-market volatility (beta ~1.39). Key stats such as the average daily volume over the past year has been around 2.80 million shares, trading with heavier-than-usual volume. Headquartered in Conshohocken, PA, AdaptHealth Corp. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Suzanne Foster, the company employs approximately 10,900 people and listed since May 31, 2018. AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States.

Our AI price prediction model suggests that AdaptHealth Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.63%, with price expected at $5.56 by October 02, 2026, within a range of $4.20 to $6.87 3-Month Outlook: Projected fall of -16.99%, reaching $4.74 by December 17, 2026, with a range of $4.36 to $5.08. 1-Year Outlook: Projected loss of -77.93%, with price at $1.26 by September 17, 2027, within a range of $0.00 to $0.00.

AdaptHealth Corp. (NASDAQ:AHCO) shares are flat 4.42% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows AdaptHealth Corp. trading at a premium to the broader market with a P/E of -3.4. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $18.65, suggesting 226.62% upside. Our AI forecast model points to short-term weakness (-2.63% over two weeks), a medium-term fall (-16.99% over three months), and a longer-term loss (-77.93% over one year), with expected trading ranges indicating moderate volatility.

AdaptHealth Corp. trades at a P/E ratio of -3.4, slightly below the S&P 500 average, with a price-to-sales ratio of 0.26 and a price-to-book ratio of 0.56 suggesting the stock is closer to book value. The P/FCF stands at 7.95, also above market averages.